Skip to main content
CME
NASDAQ Crypto Assets

CME Q3 Revenue Up 13% to $1.74B; EPS $2.89, $1.8B Buyback Year-to-Date

Arie Shkolnikov · Analysis by Wiseek AI
Sentiment info
Positive
Importance info
7
Price
$306.28
Mkt Cap
$110.132B
52W Low
$218.31
52W High
$329.16
52W Position info
40% above low
Off High info
7.0% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CME sits 40% above its 52-week low of $218.31.

Summary

CME posted Q3 revenue of $1.74 billion (up 13%) and diluted EPS of $2.89, with volume up 16% offsetting a 3% lower rate per contract. It repurchased $1.8 billion of stock in the first nine months and has $1.0 billion left on its buyback.


Key Events · Earnings and Guidance · CME

  • Q3 Revenue Jumps 13%

    Total revenues were $1,737.3 million versus $1,537.6 million a year earlier, with clearing and transaction fees up 12% to $1,378.1 million and market data up 20% to $243.1 million.

  • Net Income and EPS Rise

    Net income was $1,036.9 million, or $2.89 diluted, versus $908.0 million and $2.49 in Q3 2025; operating margin widened to 65.7% from 63.3%.

  • Volume Up, Rate Per Contract Down

    Aggregate average daily volume rose 16% to 29,445 thousand contracts, but the average rate per contract fell 3% to $0.679 as micro contracts and member trading grew.

  • Buyback: $1.8B Spent, $1.0B Left

    CME repurchased 6,432,010 Class A shares for $1.8 billion in the first nine months of 2026 at an average of $272.89; $1.0 billion remains under the $3.0 billion program.


Analysis · CME · Crypto Assets

CME's third quarter was strong across the board: revenue rose 13% to $1.74 billion and net income climbed 14% to $1.04 billion, lifting the operating margin to 65.7% from 63.3%. Volume did the work — average daily contracts rose 16% to 29.4 million — while pricing slipped 3% per contract as cheaper micro contracts and member trading took a bigger share. The company also bought back $1.8 billion of stock in the first nine months and has $1.0 billion left on its authorization, which supports per-share results. The main open item is legal: the Class B shareholder case was won at trial and post-trial motions were denied in June, but plaintiffs have appealed, so the matter is not fully closed.

How filings like this one have moved

In the 30 days to Oct 23, 2026, 29.4% of the 1556 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CME was trading at $306.28 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $110.1B. The 52-week trading range was $218.31 to $329.16. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CME - Latest Insights

CME
Oct 21, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $295.38
Real-time Price: $306.44 info
Change: +$11.06 (+4%) info
Market Cap: $110.188B info
CME
Oct 08, 2026, 3:53 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $270.85
Real-time Price: $306.44 info
Change: +$35.58 (+13%) info
Market Cap: $110.188B info
CME
Oct 02, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $263.14
Real-time Price: $306.44 info
Change: +$43.30 (+16%) info
Market Cap: $110.188B info
CME
Sep 22, 2026, 8:30 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $275.00
Real-time Price: $306.44 info
Change: +$31.44 (+11%) info
Market Cap: $110.188B info
CME
Sep 16, 2026, 3:46 AM EDT
Source: Business Line
Importance Score:
7
Price at Filing: $275.10
Real-time Price: $306.44 info
Change: +$31.33 (+11%) info
Market Cap: $110.188B info